[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

C O N M E D Corp (CNMD)

C O N M E D Corp (CNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

CONMED's Margin Recovery Thesis Depends on a Portfolio That Just Got Smaller

CONMED Corporation reports second-quarter 2026 earnings after the close on July 29, with analysts expecting $1.10 per share—down from $1.15 in the same quarter last year. The medical device maker faces a critical test as Wall Street's sentiment has deteriorated sharply, with two analysts recently downgrading to sell ratings and the consensus price target now sitting below current trading levels, raising questions about whether the company's recent string of earnings beats can offset mounting concerns about growth momentum.

CONMED Corporation is a global medical technology company specializing in surgical devices and equipment for orthopedic, general, and gynecologic procedures. The company serves hospitals and...

Fundamentals

See More
  • Market Capitalization, $K 1,310,042
  • Shares Outstanding, K 30,109
  • Annual Sales, $ 1,375 M
  • Annual Income, $ 47,060 K
  • EBIT $ 112 M
  • EBITDA $ 192 M
  • 60-Month Beta 0.93
  • Price/Sales 0.93
  • Price/Cash Flow 5.93
  • Price/Book 1.26

Options Overview Details

View History
  • Implied Volatility 53.34% (+4.72%)
  • Historical Volatility 61.95%
  • IV Percentile 56%
  • IV Rank 47.82%
  • IV High 73.64% on 04/29/26
  • IV Low 34.73% on 09/17/25
  • Expected Move (DTE 23) 1.74 (3.94%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 202
  • Volume Avg (30-Day) 377
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 1,461
  • Open Int (30-Day) 1,298
  • Expected Range 42.51 to 45.99

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.10
  • Number of Estimates 3
  • High Estimate $1.12
  • Low Estimate $1.07
  • Prior Year $1.15
  • Growth Rate Est. (year over year) -4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.10 +37.87%
on 06/30/26
46.49 -4.81%
on 07/28/26
+8.30 (+23.09%)
since 06/26/26
3-Month
31.44 +40.74%
on 06/22/26
46.49 -4.81%
on 07/28/26
+7.46 (+20.28%)
since 04/28/26
52-Week
31.44 +40.74%
on 06/22/26
56.63 -21.87%
on 09/05/25
-5.77 (-11.54%)
since 07/28/25

Most Recent Stories

More News
CONMED's Margin Recovery Thesis Depends on a Portfolio That Just Got Smaller

Barchart Research What to Expect from CNMD Earnings CNMD Generated July 28, 2026 Current Price $44.25 EPS Estimate $$1.10 Consensus Rating Hold Average Move 5.42% CONMED's Margin Recovery Thesis Depends...

CNMD : 44.25 (+1.70%)
Earnings To Watch: CONMED (CNMD) Reports Q2 Results Tomorrow

Earnings To Watch: CONMED (CNMD) Reports Q2 Results Tomorrow

CNMD : 44.25 (+1.70%)
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

CONMED Corporation (NYSE: CNMD) today announced that its AirSeal ® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used...

CNMD : 44.25 (+1.70%)
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

Professor Nikhil Vasdev to Present Results of a Recently Published Clinical Trial Featuring AirSeal ® technology

CNMD : 44.25 (+1.70%)
1 Russell 2000 Stock to Own for Decades and 2 We Avoid

1 Russell 2000 Stock to Own for Decades and 2 We Avoid

OSCR : 31.40 (+10.80%)
CNMD : 44.25 (+1.70%)
HOMB : 31.48 (+1.61%)
CONMED (CNMD) Stock Trades Up, Here Is Why

CONMED (CNMD) Stock Trades Up, Here Is Why

CNMD : 44.25 (+1.70%)
3 Healthcare Stocks We Think Twice About

3 Healthcare Stocks We Think Twice About

BAX : 24.37 (+4.41%)
CNMD : 44.25 (+1.70%)
RVTY : 111.51 (+3.18%)
3 Value Stocks Walking a Fine Line

3 Value Stocks Walking a Fine Line

DHT : 18.59 (+1.64%)
REZI : 36.65 (+4.00%)
CNMD : 44.25 (+1.70%)
3 Stocks Under $50 We Keep Off Our Radar

3 Stocks Under $50 We Keep Off Our Radar

STBA : 53.36 (+2.36%)
CNMD : 44.25 (+1.70%)
HOPE : 14.12 (+2.17%)
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2026 after the market close on Wednesday, July 29, 2026. The Company’s management...

CNMD : 44.25 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered...

See More

Key Turning Points

3rd Resistance Point 48.15
2nd Resistance Point 47.32
1st Resistance Point 45.78
Last Price 44.25
1st Support Level 43.42
2nd Support Level 42.59
3rd Support Level 41.05

See More

52-Week High 56.63
Fibonacci 61.8% 47.01
Last Price 44.25
Fibonacci 50% 44.04
Fibonacci 38.2% 41.06
52-Week Low 31.44

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.